DongKoo Bio & Pharma Co., Ltd. (KOSDAQ:006620)
South Korea flag South Korea · Delayed Price · Currency is KRW
5,760.00
-80.00 (-1.37%)
At close: Dec 5, 2025

DongKoo Bio & Pharma Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Net Income
770.312,03611,8126,6149,3279,140
Upgrade
Depreciation & Amortization
8,8747,2746,0285,6325,0544,506
Upgrade
Loss (Gain) From Sale of Assets
0-5.980-123.891.3381.62
Upgrade
Asset Writedown & Restructuring Costs
365.56665.56--0-
Upgrade
Loss (Gain) From Sale of Investments
-4,003-7,119-2,0778,869-1,090-1,985
Upgrade
Loss (Gain) on Equity Investments
4,31013,112660.61-118.281,733-726.96
Upgrade
Stock-Based Compensation
203.66251.89224.51---
Upgrade
Provision & Write-off of Bad Debts
56.45-193.35-52.8240.44241.761,370
Upgrade
Other Operating Activities
-3,0052,2951,697331.91638.041,744
Upgrade
Change in Accounts Receivable
-5,698478.4-1,333-2,8611,4311,532
Upgrade
Change in Inventory
-14,993-6,632-12,838-6,686-1,897-7,192
Upgrade
Change in Accounts Payable
-1,4044,389-3,0932,7152,399-2,040
Upgrade
Change in Other Net Operating Assets
4,217793.422,5582,40465.11,058
Upgrade
Operating Cash Flow
-10,30617,3443,58516,81917,9037,489
Upgrade
Operating Cash Flow Growth
-383.75%-78.68%-6.05%139.06%-21.23%
Upgrade
Capital Expenditures
-8,270-21,866-13,845-4,978-4,266-5,268
Upgrade
Sale of Property, Plant & Equipment
-60.66300.4411.97-
Upgrade
Sale (Purchase) of Intangibles
-1,818-3,598-2,034-6,098-1,137-192.72
Upgrade
Investment in Securities
-18,850-18,43311,851-16,2876,202-6,072
Upgrade
Other Investing Activities
20.3583.28-10639-366.43-1,059
Upgrade
Investing Cash Flow
-30,599-45,033-5,133-27,014463.93-12,564
Upgrade
Short-Term Debt Issued
-47,0297,50015,00070.7510,000
Upgrade
Long-Term Debt Issued
-9,8951,447---
Upgrade
Total Debt Issued
75,70756,9248,94715,00070.7510,000
Upgrade
Short-Term Debt Repaid
--13,528----6,883
Upgrade
Long-Term Debt Repaid
--935.5-1,126-5,966-742.12-2,536
Upgrade
Total Debt Repaid
-43,825-14,463-1,126-5,966-742.12-9,419
Upgrade
Net Debt Issued (Repaid)
31,88242,4617,8219,034-671.37581.47
Upgrade
Repurchase of Common Stock
-408.34-3,408-79.9-2,995-1,998-
Upgrade
Dividends Paid
-3,245-3,313-3,038-2,804-942.94-942.92
Upgrade
Other Financing Activities
-68.351,45449-50-76.10
Upgrade
Financing Cash Flow
28,16037,1944,7523,185-3,688-361.45
Upgrade
Foreign Exchange Rate Adjustments
-61.29154.83-4.74-33.91-2.27-23.18
Upgrade
Miscellaneous Cash Flow Adjustments
---0-0-0
Upgrade
Net Cash Flow
-12,8079,6603,199-7,04314,676-5,460
Upgrade
Free Cash Flow
-18,577-4,522-10,26011,84113,6372,221
Upgrade
Free Cash Flow Growth
----13.16%514.06%-74.46%
Upgrade
Free Cash Flow Margin
-7.79%-1.81%-4.76%6.07%8.79%1.59%
Upgrade
Free Cash Flow Per Share
-671.22-165.59-371.44426.63482.5778.50
Upgrade
Cash Interest Paid
3,5022,8281,672902.19362.76401.35
Upgrade
Cash Income Tax Paid
3,7872,7754,1043,0761,392730.99
Upgrade
Levered Free Cash Flow
-24,678-9,684-15,354-140.4310,027-
Upgrade
Unlevered Free Cash Flow
-22,436-7,875-14,254509.1410,286-
Upgrade
Change in Working Capital
-17,878-970.91-14,706-4,4271,999-6,642
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.